We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-5.61%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$267M
AUM Growth
-$170M
Cap. Flow
-$43.3M
Cap. Flow %
-16.21%
Top 10 Hldgs %
79.28%
Holding
746
New
321
Increased
50
Reduced
153
Closed
192
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERO
176
DELISTED
CERo Therapeutics
CERO
$16K 0.01%
+1
New +$20.1K
BMAC
177
DELISTED
Black Mountain Acquisition Corp.
BMAC
$16K 0.01%
+1,561
New +$15.6K
COVA
178
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
$16K 0.01%
+1,600
New +$15.8K
DHBC
179
DELISTED
DHB Capital Corp. Class A common stock
DHBC
$16K 0.01%
+1,600
New +$15.7K
IPOD
180
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$16K 0.01%
+1,600
New +$16K
AAL icon
181
American Airlines Group
AAL
$10.2B
$15K 0.01%
1,238
-1,120
-47% -$15.6K
COCH icon
182
Envoy Medical
COCH
$51.3M
$15K 0.01%
+1,500
New +$14.7K
DDOG icon
183
Datadog
DDOG
$95.6B
$15K 0.01%
167
-190
-53% -$19.1K
OBIO icon
184
Orchestra BioMed
OBIO
$239M
$15K 0.01%
1,542
-48,458
-97% -$480K
Z icon
185
Zillow
Z
$7.71B
$15K 0.01%
510
-634
-55% -$22K
INTE
186
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
$15K 0.01%
+1,500
New +$14.9K
NFYS
187
DELISTED
Enphys Acquisition Corp.
NFYS
$15K 0.01%
+1,500
New +$14.6K
HCMA
188
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$15K 0.01%
+1,493
New +$15K
SAGA
189
DELISTED
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
$15K 0.01%
+1,500
New +$15K
FICV
190
DELISTED
Frontier Investment Corp Class A Ordinary Shares
FICV
$15K 0.01%
+1,500
New +$14.6K
ENER
191
DELISTED
Accretion Acquisition Corp
ENER
$15K 0.01%
+1,500
New +$14.8K
FRXB
192
DELISTED
Forest Road Acquisition Corp. II
FRXB
$15K 0.01%
+1,500
New +$14.7K
NSTC
193
DELISTED
Northern Star Investment Corp. III
NSTC
$15K 0.01%
+1,510
New +$14.8K
VBOC
194
DELISTED
Viscogliosi Brothers Acquisition Corp Common Stock
VBOC
$15K 0.01%
+1,500
New +$14.9K
FTPA
195
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
$15K 0.01%
+1,500
New +$14.7K
CLAA
196
DELISTED
Colonnade Acquisition Corp. II
CLAA
$15K 0.01%
+1,500
New +$14.8K
PDOT
197
DELISTED
Peridot Acquisition Corp. II
PDOT
$15K 0.01%
+1,544
New +$15.2K
ITQ
198
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$15K 0.01%
+1,500
New +$14.8K
BIOT
199
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$15K 0.01%
+1,510
New +$14.9K
MIT
200
DELISTED
Mason Industrial Technology, Inc.
MIT
$15K 0.01%
1,553
+547
+54% +$5.35K

Similar funds

Elequin Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Elequin Capital held 746 positions worth $267M, down 39% from $437M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Elequin Capital withdrew a net $43.3M in Q3 2022, closing 192 positions and reducing 153 holdings. Its most notable exit was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 9.4% a quarter earlier, followed by Real Estate and Technology.

Against the trend, Elequin Capital opened a new position in Stanley Black & Decker, Inc. worth $41.1M.

  • Elequin Capital's largest Q3 2022 buy was Stanley Black & Decker, Inc.: 850,245 shares worth $41.1M.
  • Elequin Capital added most to South Jersey Industries, Inc. Corporate Units in Q3 2022, an estimated $21.4M increase.
  • Elequin Capital's biggest Q3 2022 reduction was Austerlitz Acquisition Corporation II, cutting an estimated $1.01M.
  • Elequin Capital fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q3 2022, selling an estimated $140M.
  • Elequin Capital's ten largest holdings make up 79% of its $267M portfolio in Q3 2022.
  • Elequin Capital opened 321 new positions and closed 192 in Q3 2022.
  • Elequin Capital's portfolio value fell 39% quarter-over-quarter to $267M.

Based on Elequin Capital's 13F filing for Q3 2022, filed 10 Nov 2022.